We are live on ! Find out more
BIVI icon

BioVie
BIVI

33 hedge funds and large institutions have $1.44M invested in BioVie in 2026 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

7% more capital invested

Capital invested by funds: $1.34M → $1.44M (+$97.7K)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

1.71% less ownership

Funds ownership: 15.38% → 13.67% (-1.7%)

6% less funds holding

Funds holding: 35 → 33 (-2)

Holders
33
Holders Change
-2
Holders Change %
-5.71%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
7
Reduced
5
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$51.3K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$37K
3
Citadel Advisors
Citadel Advisors
Florida
+$34.9K
4
HF
HRT Financial
New York
+$30.2K
5
Morgan Stanley
Morgan Stanley
New York
+$19.3K

Top Sellers

Rank Fund Capital Flow
1
DS
DRW Securities
Illinois
-$149K
2
Two Sigma Investments
Two Sigma Investments
New York
-$24.8K
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$20.9K
4
Squarepoint
Squarepoint
New York
-$16.4K
5
Cerity Partners
Cerity Partners
New York
-$14.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
DC
1
Diametric Capital
Massachusetts
$518K – – –
PCM
2
Prelude Capital Management
New York
$129K – – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$118K +$37K +28,822 +52%
VCM
4
Vanguard Capital Management
Pennsylvania
$118K +$108K +84,067 New
Morgan Stanley
5
Morgan Stanley
New York
$105K +$19.3K +14,999 +25%
PTC
6
Philadelphia Trust Company
Pennsylvania
$105K – – –
Renaissance Technologies
7
Renaissance Technologies
New York
$95.1K +$51.3K +39,900 +142%
Citadel Advisors
8
Citadel Advisors
Florida
$63.4K +$34.9K +27,142 +150%
VFT
9
Vanguard Fiduciary Trust
Pennsylvania
$52.6K +$48.3K +37,557 New
HF
10
HRT Financial
New York
$32K +$30.2K +23,482 New
Jane Street
11
Jane Street
New York
$31.9K +$15.8K +12,316 +118%
XT
12
XTX Topco
Cayman Islands
$29.7K -$525 -409 -2%
Northern Trust
13
Northern Trust
Illinois
$19.9K – – –
TRCT
14
Tower Research Capital (TRC)
New York
$10.6K +$8.89K +6,923 +1,122%
AF
15
Allworth Financial
California
$7.84K +$4.63K +3,600 +180%
Citigroup
16
Citigroup
New York
$4.43K +$4.07K +3,164 New
PNC Financial Services Group
17
PNC Financial Services Group
Pennsylvania
$1.4K – – –
SS
18
SBI Securities
Japan
$323 -$6 -5 -2%
VGA
19
Vanguard Global Advisers
Pennsylvania
$80 +$73 +57 New
Osaic Holdings
20
Osaic Holdings
Arizona
$77 – – –
Wells Fargo
21
Wells Fargo
California
$38 -$3 -2 -7%
NA
22
NewEdge Advisors
Louisiana
$14 – – –
TCM
23
Tradewinds Capital Management
Washington
$14 – – –
UBS Group
24
UBS Group
Switzerland
$8 -$983 -765 -99%
FP
25
Financial Perspectives
Minnesota
$8 – – –
1
2

BIVI Hedge Fund Activity: Q1 2026 in Review

33 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q1 2026, worth a combined $1.44M — up 7.3% from $1.34M a quarter earlier.

Fund positioning in BIVI was balanced in Q1 2026: 7 funds opened new positions, 7 closed out, 7 added to existing stakes and 5 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $51.3K. The largest seller was DRW Securities, exiting entirely with an estimated $149K sold.

  • 33 institutional investors held BioVie (BIVI) as of Q1 2026, down from 35 in Q4 2025.
  • Funds reported $1.44M of BioVie stock for Q1 2026, up 7.3% quarter-over-quarter.
  • 7 funds opened new BioVie positions in Q1 2026 and 7 closed out, a net change of 0 holders.
  • The largest BioVie buyer in Q1 2026 was Renaissance Technologies, an estimated $51.3K added.
  • The largest BioVie seller in Q1 2026 was DRW Securities, an estimated $149K sold.

Based on aggregated 13F filings for Q1 2026.